Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Penetratin-mediated delivery enhances the antitumor activity of the cationic antimicrobial peptide Magainin II.

  • Authors : Liu S; Key Lab of Transplant Engineering and Immunology, Ministry of Health, West China Hospital, Sichuan University , Chengdu 610041, China .; Yang H

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*pharmacology ; Carrier Proteins/Carrier Proteins/Carrier Proteins/*pharmacology ; Drug Carriers/Drug Carriers/Drug Carriers/*pharmacology

  • Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2013 May; Vol. 28 (4), pp. 289-97. Date of Electronic Publication: 2013 Jan 03.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic

Record details

×
Academic Journal

Discovery of Cancer-Specific and Independent Prognostic Gene Subsets of the Slit-Robo Family Using TCGA-PANCAN Datasets.

  • Authors : Ozhan A; UNAM-National Nanotechnology Research Center, Institute of Material Science and Nanotechnology, Bilkent University, Ankara, Turkey.; Tombaz M

Subjects: Neoplasms*/Neoplasms*/Neoplasms*/genetics ; Nerve Tissue Proteins*/Nerve Tissue Proteins*/Nerve Tissue Proteins*/genetics; Cell Differentiation

  • Source: Omics : a journal of integrative biology [OMICS] 2021 Dec; Vol. 25 (12), pp. 782-795. Date of Electronic Publication: 2021 Nov 10.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101131135 Publication Model: Print-Electronic

Record details

×
Academic Journal

Oxidative Stress and Cancer Development: Are Noncoding RNAs the Missing Links?

  • Authors : D'Souza LC; Division of Environmental Health and Toxicology, Nitte University Centre for Science Education and Research (NUCSER), Mangaluru, India.; Mishra S

Subjects: Disease Susceptibility* ; Oxidative Stress*; Neoplasms/Neoplasms/Neoplasms/*etiology

  • Source: Antioxidants & redox signaling [Antioxid Redox Signal] 2020 Dec 10; Vol. 33 (17), pp. 1209-1229. Date of Electronic Publication: 2020 Jan 24.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100888899 Publication Model: Print-Electronic

Record details

×
Academic Journal

2-Hydroxyglutarate in Cancer Cells.

  • Authors : Ježek P; Department of Mitochondrial Physiology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic.

Subjects: Disease Susceptibility*; Glutarates/Glutarates/Glutarates/*metabolism ; Neoplasms/Neoplasms/Neoplasms/*etiology

  • Source: Antioxidants & redox signaling [Antioxid Redox Signal] 2020 Nov 01; Vol. 33 (13), pp. 903-926. Date of Electronic Publication: 2020 Jan 22.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100888899 Publication Model: Print-Electronic

Record details

×
Academic Journal

NOS2 as an Emergent Player in Progression of Cancer.

  • Authors : Thomas DD; 1 Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois at Chicago , Chicago, Illinois.; Wink DA

Subjects: Up-Regulation*; Neoplasms/Neoplasms/Neoplasms/*metabolism ; Nitric Oxide Synthase Type II/Nitric Oxide Synthase Type II/Nitric Oxide Synthase Type II/*metabolism

  • Source: Antioxidants & redox signaling [Antioxid Redox Signal] 2017 Jun 10; Vol. 26 (17), pp. 963-965.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100888899 Publication Model: Print Cited

Record details

×
Academic Journal

siRNA-mediated integrin-linked kinase suppression: nonspecific effects of siRNA/cationic liposome complexes trigger changes in the expression of phosphorylated-AKT and mTOR independently of ILK silencing.

  • Authors : Verreault M; Advanced Therapeutics, British Columbia Cancer Research Center, Vancouver, British Columbia, Canada. ; Bally MB

Subjects: Drug Delivery Systems*; Neoplasms/Neoplasms/Neoplasms/*therapy ; Protein Kinases/Protein Kinases/Protein Kinases/*biosynthesis

  • Source: Oligonucleotides [Oligonucleotides] 2009 Jun; Vol. 19 (2), pp. 129-40.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101188415 Publication Model: Print Cited

Record details

×
Academic Journal

Protein- and DNA-based active immunotherapy targeting interleukin-13 receptor alpha2.

  • Authors : Mintz A; Brain Tumor Center of Excellence, Department of Neurosurgery & Radiology, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1082, USA. ; Gibo DM

Subjects: Cancer Vaccines/Cancer Vaccines/Cancer Vaccines/*therapeutic use ; Immunotherapy, Active/Immunotherapy, Active/Immunotherapy, Active/*methods ; Interleukin-13 Receptor alpha2 Subunit/Interleukin-13 Receptor alpha2 Subunit/Interleukin-13 Receptor alpha2 Subunit/*metabolism

  • Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2008 Oct; Vol. 23 (5), pp. 581-9.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Intracavitary radioimmunotherapy to treat solid tumors.

  • Authors : Aarts F; Department of Surgery, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. ; Bleichrodt RP

Subjects: Radioimmunotherapy*; Brachytherapy/Brachytherapy/Brachytherapy/*methods ; Neoplasms/Neoplasms/Neoplasms/*radiotherapy

  • Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2008 Feb; Vol. 23 (1), pp. 92-107.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print Cited Medium:

Record details

×
  • 1-8 of  8 results for ""Glioma""